Meng-Yuan Dai
3PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Nov 18, 2024
Correction: Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates.Yu-Ying Shi, Gang Fan, Ruirong Tan
|Sep 30, 2024
Treating ICB-resistant cancer by inhibiting PD-L1 via DHHC3 degradation induced by cell penetrating peptide-induced chimera conjugates.Yu-Ying Shi, Gang Fan, Ruirong Tan
|Mar 11, 2021
Residual Tumor Diameter Predicts Progression After Primary Debulking Surgery of Ovarian Clear Cell Carcinoma (OCCC): Clinicopathologic Study of Stage II-IV OCCC Patients from a Single Institution.Yuying Shi, Mengyuan Dai, Yaxing Zhang
Pageof 1
